Sponsored by
I was hoping there would be more of a difference, like the phase 1 trial showed (that trial showed a 50% 5 year survival). However, there were no side effects, and it is a simple shot in the arm, and it did increase progression free survival by 2 or 3 months. We do not have all of the details yet so there may be some subgroups that did benefit a lot.
Click HERE for the press release